当代耐久性左心室辅助装置支持患者的主动脉瓣反流:术前与术后评估及管理的最新综述
该综述聚焦HeartMate 3耐久性左心室辅助装置(dLVAD)支持期间主动脉瓣反流(AI)的发生与管理。约8%的患者在1年内出现中度或更差AI,且AI随时间进展并与右心衰频率增加相关。管理以预防为首选,包括植入时处理瓣膜及避免过高流量和高血压,设备升速、外科或经导管瓣膜干预可用于持续显著AI。
要点
- 约8%的HeartMate 3患者1年内出现中度或更差AI,且随时间进展。
- AI进展与右心衰、心律失常和心肾综合征等血流动力学事件交织。
- 一线干预为预防:植入时处理瓣膜、避免过高流量和高血压。
核心结论
- HeartMate 3支持期间AI可导致泵输出不足和反复心衰症状,管理以预防为首选。
研究设计与样本
- 最新综述,总结HeartMate 3耐久性左心室辅助装置支持患者AI的术前和术后评估与管理。
主要发现
- 约8%的患者在1年内出现中度或更差AI,研究提示AI随时间继续进展并与右心衰频率增加相关。
- AI进展常与右心衰、心律失常和心肾综合征等其他血流动力学相关事件交织。
- 设备升速可用于尝试克服反流病变,但长期仍需预期AI进展。
关键数值与推荐
- 约8%的HeartMate 3支持患者在1年内发生中度或更差AI。
- 外科或经导管主动脉瓣干预可考虑用于药物治疗后仍持续显著AI的dLVAD患者,但均有风险。
临床怎么用
- 一线管理为预防:dLVAD植入时对功能不全瓣膜行外科干预,长期支持中避免过高设备流量和高血压。
- 设备升速可尝试克服反流病变,但应预期长期AI进展。
- 对药物治疗后仍持续显著AI者,可考虑外科或经导管主动脉瓣干预。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The development of aortic insufficiency (AI) during HeartMate 3 durable left ventricular assist device (dLVAD) support can lead to ineffective pump output and recurrent heart failure symptoms. Progression of AI often comingles with the occurrence of other hemodynamic-related events encountered during LVAD support, including right heart failure, arrhythmias, and cardiorenal syndrome. While data on AI burdens and clinical impact are still insufficient in patients on HeartMate 3 support, moderate or worse AI occurs in approximately 8% of patients by 1 year and studies suggest AI continues to progress over time and is associated with increased frequency of right heart failure. The first line intervention for AI management is prevention, undertaking surgical intervention on the insufficient valve at the time of dLVAD implant and avoiding excessive device flows and hypertension during long-term support. Device speed augmentation may then be undertaken to try and overcome the insufficient lesion, but the progression of AI should be anticipated over the long term. Surgical or transcatheter aortic valve interventions may be considered in dLVAD patients with significant persistent AI despite medical management, but neither intervention is without risk. It is imperative that future studies of dLVAD support capture AI in clinical end-points using uniform assessment and grading of AI severity by individuals trained in AI assessment during dLVAD support.
引用
- Saeed D, Grinstein J, Kremer J, et al. Aortic insufficiency in the patient on contemporary durable left ventricular assist device support: A state-of-the-art review on preoperative and postoperative assessment and management. J Heart Lung Transplant. 2024. PMID: 39069161. doi:10.1016/j.healun.2024.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。